GlassScriptPhysician profile
Douglas P Roegner
NPI 1396725503
$6,035.40
in general payments reported to CMS, 2019-2025
43 companies · $65.69 in 2025
The $65.69 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,436 · 2020: $362 · 2021: $622 · 2022: $1,012 · 2023: $1,650 · 2024: $888 · 2025: $65.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,602.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $739.45 | 2019-2024 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $596.77 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $574.84 | 2019-2024 | Erleada, Akeega, Balversa |
| Dendreon Pharmaceuticals LLC | $524.21 | 2019-2024 | Provenge |
| Abbvie INC. | $274.89 | 2019-2024 | Lupron Depot |
| Astrazeneca Pharmaceuticals LP | $253.90 | 2023-2025 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $251.65 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $195.90 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $190.22 | 2019-2024 | Xiaflex, Aveed |
| Pfizer INC. | $186.07 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $177.06 | 2020-2024 | Lynparza, Keytruda, Welireg |
| Myovant Sciences INC. | $173.95 | 2022 | |
| Organogenesis INC. | $164.38 | 2019-2022 | |
| Verity Pharmaceuticals INC. | $162.27 | 2022-2024 | Trelstar |
| Travere Therapeutics, INC. | $160.75 | 2019-2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Roegner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.